Claudin-5: gatekeeper of neurological function

被引:0
|
作者
Chris Greene
Nicole Hanley
Matthew Campbell
机构
[1] Smurfit Institute of Genetics,Trinity College Dublin
关键词
Blood–brain barrier; Endothelial cell; Tight junction; Claudin-5;
D O I
暂无
中图分类号
学科分类号
摘要
Tight junction proteins of the blood–brain barrier are vital for maintaining integrity of endothelial cells lining brain blood vessels. The presence of these protein complexes in the space between endothelial cells creates a dynamic, highly regulated and restrictive microenvironment that is vital for neural homeostasis. By limiting paracellular diffusion of material between blood and brain, tight junction proteins provide a protective barrier preventing the passage of unwanted and potentially damaging material. Simultaneously, this protective barrier hinders the therapeutic effectiveness of central nervous system acting drugs with over 95% of small molecule therapeutics unable to bypass the blood–brain barrier. At the blood–brain barrier, claudin-5 is the most enriched tight junction protein and its dysfunction has been implicated in neurodegenerative disorders such as Alzheimer’s disease, neuroinflammatory disorders such as multiple sclerosis as well as psychiatric disorders including depression and schizophrenia. By regulating levels of claudin-5, it is possible to abrogate disease symptoms in many of these disorders. This review will give an overview of the blood–brain barrier and the role of tight junction complexes in maintaining blood–brain barrier integrity before focusing on the role of claudin-5 and its regulation in homeostatic and pathological conditions. We will also summarise therapeutic strategies to restore integrity of cerebral vessels by targeting tight junction protein complexes.
引用
收藏
相关论文
共 50 条
  • [1] Claudin-5: gatekeeper of neurological function
    Greene, Chris
    Hanley, Nicole
    Campbell, Matthew
    FLUIDS AND BARRIERS OF THE CNS, 2019, 16 (1)
  • [2] Claudin-5 decreases alveolar epithelial barrier function
    Findley, Mary Katherine
    Ward, Christina
    Smith, Tekla
    Guidot, David M.
    Margulies, Susan S.
    Koval, Michael H.
    FASEB JOURNAL, 2008, 22
  • [3] Tightening Mechanism of Claudin-5
    Blasig, I. E.
    Winkler, L.
    Wolburg, H.
    Piehl, C.
    Mueller, S.
    Krause, G.
    Piontek, J.
    MOLECULAR BIOLOGY OF THE CELL, 2006, 17
  • [4] Alteplase Improves Neurological Function and Affects Expression of SDF-1 and Claudin-5 in Rats with Acute Cerebral Infarction
    Liexiang Meiping Dong
    Yi Cao
    Zhiwei Mao
    Neurochemical Journal, 2022, 16 : 456 - 464
  • [5] Alteplase Improves Neurological Function and Affects Expression of SDF-1 and Claudin-5 in Rats with Acute Cerebral Infarction
    Dong, Meiping
    Cao, Liexiang
    Mao, Yi
    Zhao, Zhiwei
    NEUROCHEMICAL JOURNAL, 2022, 16 (04) : 456 - 464
  • [6] CLAUDIN-5 AS A THERAPEUTIC TARGET IN SCHIZOPHRENIA
    Campbell, Matthew
    SCHIZOPHRENIA BULLETIN, 2019, 45 : S100 - S100
  • [7] Claudin-5 is expressed in human epidermis
    Peltonen, S.
    Riehokainen, J.
    Pummi, K.
    Peltonen, J.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 : 20 - 20
  • [8] Cardiac Pathology Is Worsened by Loss of the Cell Junction Protein Claudin-5 and Improved by Claudin-5 Gene Therapy
    Delfin, Dawn A.
    Schill, Kevin E.
    Xu, Ying
    Swager, Sarah
    Janssen, Paul M. L.
    Rafael-Fortney, Jill A.
    CIRCULATION RESEARCH, 2012, 111 (04)
  • [9] Expression of claudin-5 in hepatoid gland biopsies
    Jakab, Csaba
    Rusvai, Miklos
    Galfi, Peter
    Mandoki, Mira
    Demeter, Zoltan
    Szabo, Zoltan
    Kulka, Janina
    VETERINARY DERMATOLOGY, 2010, 21 (03) : 276 - 281
  • [10] Expression of claudin-5 in dermal vascular endothelia
    Morita, K
    Sasaki, H
    Furuse, K
    Furuse, M
    Tsukita, S
    Miyachi, Y
    EXPERIMENTAL DERMATOLOGY, 2003, 12 (03) : 289 - 295